Blue Owl Capital Holdings LP Cullinan Oncology, Inc. Transaction History
Blue Owl Capital Holdings LP
- $185 Million
- Q2 2025
A detailed history of Blue Owl Capital Holdings LP transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 2,385,972 shares of CGEM stock, worth $17.3 Million. This represents 9.73% of its overall portfolio holdings.
Number of Shares
2,385,972
Previous 2,435,972
2.05%
Holding current value
$17.3 Million
Previous $18.4 Million
2.57%
% of portfolio
9.73%
Previous 9.53%
Shares
7 transactions
Others Institutions Holding CGEM
# of Institutions
152Shares Held
68.4MCall Options Held
15.6KPut Options Held
17.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$55.6 Million10.72% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$41.8 Million1.91% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$28.1 Million0.74% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$25.8 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$24.8 Million15.23% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $332M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...